We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+15.01%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.52B
AUM Growth
+$204M
Cap. Flow
+$511M
Cap. Flow %
20.25%
Top 10 Hldgs %
77.93%
Holding
47
New
3
Increased
4
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ESTC icon
Elastic
ESTC
+$430M
2
MRKR icon
Marker Therapeutics
MRKR
+$36.4M
3
TPST icon
Tempest Therapeutics
TPST
+$18.6M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$10.1M
5
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$7.04M

Top Sells

Rank Stock Value
1
AYTU icon
AYTU BioPharma
AYTU
+$6K

Sector Composition

Rank Sector Weight
1 Healthcare 79.53%
2 Technology 18.54%
3 Industrials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SURF
26
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$14.1M 0.56%
3,315,149
– –
TPST icon
27
Tempest Therapeutics
TPST
$14M
$14M 0.56%
+9,060
New +$18.6M
BE icon
28
Bloom Energy
BE
$64.3B
$13.3M 0.53%
1,333,333
– –
DZSI
29
DELISTED
DZS Inc. Common Stock
DZSI
$13.3M 0.53%
956,255
– –
CSBR icon
30
Champions Oncology
CSBR
$80M
$12.2M 0.48%
1,562,500
– –
VRNA
31
DELISTED
Verona Pharma
VRNA
$11M 0.44%
1,219,674
– –
NITE
32
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$8.23M 0.33%
714,285
– –
RIGL icon
33
Rigel Pharmaceuticals
RIGL
$693M
$7.46M 0.3%
324,315
– –
GNCA
34
DELISTED
Genocea Biosciences, Inc.
GNCA
$7.17M 0.28%
3,125,000
– –
ARQL
35
DELISTED
Arqule Inc
ARQL
$6.98M 0.28%
2,520,316
– –
AKAO
36
DELISTED
Achaogen Inc
AKAO
$6.42M 0.25%
5,215,128
– –
XFOR icon
37
X4 Pharmaceuticals
XFOR
$386M
$4.64M 0.18%
11,111
– –
PHXM
38
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.23M 0.17%
62,500
– –
CTIC
39
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.74M 0.11%
3,750,000
– –
TCON
40
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$2.18M 0.09%
17,336
– –
TRIL
41
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.14M 0.08%
1,250,000
– –
ELGX
42
DELISTED
Endologix Inc
ELGX
$1.78M 0.07%
249,020
– –
TRVN
43
DELISTED
Trevena, Inc.
TRVN
$1.64M 0.07%
6,099
– –
RGLS
44
DELISTED
Regulus Therapeutics
RGLS
$852K 0.03%
91,575
– –
AKTX
45
Akari Therapeutics
AKTX
$12.9M
$710K 0.03%
565
– –
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$539K 0.02%
37,094
– –
AYTU icon
47
AYTU BioPharma
AYTU
$24.1M
– –
-11
Closed -$6K
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q4 2018 Portfolio in Review

As of Q4 2018, NEA Management Company held 47 positions worth $2.52B, up 8.8% from $2.32B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

NEA Management Company deployed $511M of net new capital in Q4 2018, opening 3 new positions and adding to 4 existing holdings. Its largest new stake was Elastic: 6,353,498 shares worth $454M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 94% a quarter earlier, followed by Technology and Industrials.

On the sell side, the most notable exit was AYTU BioPharma, an estimated $6K sold.

  • NEA Management Company's largest Q4 2018 buy was Elastic: 6,353,498 shares worth $454M.
  • NEA Management Company added most to Ra Pharmaceuticals, Inc. Common Stock in Q4 2018, an estimated $10.1M increase.
  • NEA Management Company fully exited AYTU BioPharma in Q4 2018, selling an estimated $6K.
  • NEA Management Company's ten largest holdings make up 78% of its $2.52B portfolio in Q4 2018.
  • NEA Management Company opened 3 new positions and closed 1 in Q4 2018.
  • NEA Management Company's portfolio value rose 8.8% quarter-over-quarter to $2.52B.

Based on NEA Management Company's 13F filing for Q4 2018, filed 18 Jan 2019.